Wird geladen...
Leveraging Population‐Based Clinical Quantitative Phenotyping for Drug Repositioning
Computational drug repositioning methods can scalably nominate approved drugs for new diseases, with reduced risk of unforeseen side effects. The majority of methods eschew individual‐level phenotypes despite the promise of biomarker‐driven repositioning. In this study, we propose a framework for di...
Gespeichert in:
| Veröffentlicht in: | CPT Pharmacometrics Syst Pharmacol |
|---|---|
| Hauptverfasser: | , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
John Wiley and Sons Inc.
2018
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5824113/ https://ncbi.nlm.nih.gov/pubmed/28941007 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/psp4.12258 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|